ID   HGG-02
AC   CVCL_IR54
DR   cancercelllines; CVCL_IR54
DR   IARC_TP53; 28524
DR   Wikidata; Q54887266
RX   PubMed=20195615;
RX   PubMed=24270553;
CC   Sequence variation: Gene deletion; HGNC; HGNC:3236; EGFR; Zygosity=Heterozygous (PubMed=20195615).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=20195615).
CC   Derived from site: In situ; Brain, right parieto-occipital lobe.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14-15Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
RX   PubMed=20195615; DOI=10.1007/s00381-010-1110-5;
RA   Veselska R., Skoda J., Loja T., Zitterbart K., Pavelka Z.,
RA   Smardova J., Valaskova I., Hermanova M., Sterba J.;
RT   "An unusual loss of EGFR gene copy in glioblastoma multiforme in a
RT   child: a case report and analysis of a successfully derived HGG-02
RT   cell line.";
RL   Childs Nerv. Syst. 26:841-846(2010).
//
RX   PubMed=24270553; DOI=10.3892/or.2013.2864;
RA   Skoda J., Neradil J., Zitterbart K., Sterba J., Veselska R.;
RT   "EGFR signaling in the HGG-02 glioblastoma cell line with an unusual
RT   loss of EGFR gene copy.";
RL   Oncol. Rep. 31:480-487(2014).
//